Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1038/s41374-020-0411-x
- Scopus: eid_2-s2.0-85083377437
- PMID: 32205858
- WOS: WOS:000521525000001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Altered glycosylation of glycodelin in endometrial carcinoma
Title | Altered glycosylation of glycodelin in endometrial carcinoma |
---|---|
Authors | |
Issue Date | 2020 |
Publisher | Springer for United States and Canadian Academy of Pathology (USCAP). The Journal's web site is located at http://www.nature.com/labinvest/ |
Citation | Laboratory Investigation, 2020, v. 100 n. 7, p. 1014-1025 How to Cite? |
Abstract | Glycodelin is a major glycoprotein expressed in reproductive tissues, like secretory and decidualized endometrium. It has several reproduction related functions that are dependent on specific glycosylation, but it has also been found to drive differentiation of endometrial carcinoma cells toward a less malignant phenotype. Here we aimed to elucidate whether the glycosylation and function of glycodelin is altered in endometrial carcinoma as compared with a normal endometrium. We carried out glycan structure analysis of glycodelin expressed in HEC-1B human endometrial carcinoma cells (HEC-1B Gd) by mass spectrometry glycomics strategies. Glycans of HEC-1B Gd were found to comprise a typical mixture of high-mannose, hybrid, and complex-type N-glycans, often containing undecorated LacNAc (Galβ1–4GlcNAc) antennae. However, several differences, as compared with previously reported glycan structures of normal human decidualized endometrium-derived glycodelin isoform, glycodelin-A (GdA), were also found. These included a lower level of sialylation and more abundant poly-LacNAc antennae, some of which are fucosylated. This allowed us to select lectins that showed different binding to these classes of glycodelin. Despite the differences in glycosylation between HEC-1B Gd and GdA, both showed similar inhibitory activity on trophoblast cell invasion and peripheral blood mononuclear cell proliferation. For the detection of cancer associated glycodelin, we established a novel in situ proximity-ligation based histochemical staining method using a specific glycodelin antibody and UEAI lectin. We found that the UEAI reactive glycodelin was abundant in endometrial carcinoma, but virtually absent in normal endometrial tissue even when glycodelin was strongly expressed. In conclusion, we established a histochemical staining method for the detection of endometrial carcinoma-associated glycodelin and showed that this specific glycodelin is exclusively expressed in cancer, not in normal endometrium. Similar methods can be used for studies of other glycoproteins. |
Persistent Identifier | http://hdl.handle.net/10722/284950 |
ISSN | 2023 Impact Factor: 5.1 2023 SCImago Journal Rankings: 1.243 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hautala, LC | - |
dc.contributor.author | Pang, PC | - |
dc.contributor.author | Antonopoulos, A | - |
dc.contributor.author | Pasanen, A | - |
dc.contributor.author | Lee, CL | - |
dc.contributor.author | Chiu, PCN | - |
dc.contributor.author | Yeung, WSB | - |
dc.contributor.author | Loukovaara, M | - |
dc.contributor.author | Bützow, R | - |
dc.contributor.author | Haslam, SM | - |
dc.contributor.author | Dell, A | - |
dc.contributor.author | Koistinen, H | - |
dc.date.accessioned | 2020-08-07T09:04:45Z | - |
dc.date.available | 2020-08-07T09:04:45Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Laboratory Investigation, 2020, v. 100 n. 7, p. 1014-1025 | - |
dc.identifier.issn | 0023-6837 | - |
dc.identifier.uri | http://hdl.handle.net/10722/284950 | - |
dc.description.abstract | Glycodelin is a major glycoprotein expressed in reproductive tissues, like secretory and decidualized endometrium. It has several reproduction related functions that are dependent on specific glycosylation, but it has also been found to drive differentiation of endometrial carcinoma cells toward a less malignant phenotype. Here we aimed to elucidate whether the glycosylation and function of glycodelin is altered in endometrial carcinoma as compared with a normal endometrium. We carried out glycan structure analysis of glycodelin expressed in HEC-1B human endometrial carcinoma cells (HEC-1B Gd) by mass spectrometry glycomics strategies. Glycans of HEC-1B Gd were found to comprise a typical mixture of high-mannose, hybrid, and complex-type N-glycans, often containing undecorated LacNAc (Galβ1–4GlcNAc) antennae. However, several differences, as compared with previously reported glycan structures of normal human decidualized endometrium-derived glycodelin isoform, glycodelin-A (GdA), were also found. These included a lower level of sialylation and more abundant poly-LacNAc antennae, some of which are fucosylated. This allowed us to select lectins that showed different binding to these classes of glycodelin. Despite the differences in glycosylation between HEC-1B Gd and GdA, both showed similar inhibitory activity on trophoblast cell invasion and peripheral blood mononuclear cell proliferation. For the detection of cancer associated glycodelin, we established a novel in situ proximity-ligation based histochemical staining method using a specific glycodelin antibody and UEAI lectin. We found that the UEAI reactive glycodelin was abundant in endometrial carcinoma, but virtually absent in normal endometrial tissue even when glycodelin was strongly expressed. In conclusion, we established a histochemical staining method for the detection of endometrial carcinoma-associated glycodelin and showed that this specific glycodelin is exclusively expressed in cancer, not in normal endometrium. Similar methods can be used for studies of other glycoproteins. | - |
dc.language | eng | - |
dc.publisher | Springer for United States and Canadian Academy of Pathology (USCAP). The Journal's web site is located at http://www.nature.com/labinvest/ | - |
dc.relation.ispartof | Laboratory Investigation | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.title | Altered glycosylation of glycodelin in endometrial carcinoma | - |
dc.type | Article | - |
dc.identifier.email | Lee, CL: kcllee@hku.hk | - |
dc.identifier.email | Chiu, PCN: pchiucn@hku.hk | - |
dc.identifier.email | Yeung, WSB: wsbyeung@hku.hk | - |
dc.identifier.authority | Lee, CL=rp02515 | - |
dc.identifier.authority | Chiu, PCN=rp00424 | - |
dc.identifier.authority | Yeung, WSB=rp00331 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1038/s41374-020-0411-x | - |
dc.identifier.pmid | 32205858 | - |
dc.identifier.pmcid | PMC7312397 | - |
dc.identifier.scopus | eid_2-s2.0-85083377437 | - |
dc.identifier.hkuros | 312374 | - |
dc.identifier.hkuros | 327342 | - |
dc.identifier.volume | 100 | - |
dc.identifier.issue | 7 | - |
dc.identifier.spage | 1014 | - |
dc.identifier.epage | 1025 | - |
dc.identifier.isi | WOS:000521525000001 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 0023-6837 | - |